Instead, metformin, a safe and popular anti-diabetic drug, previously shown to reduce cellular bFGF expression and with anti-cancer effect in obese settings [87,88], reduced vessel density and re-sensitized to anti-VEGF therapy in obese mice. This evidence concerns the gene VEGFA and cancer.